Prior studies have shown increased infiltrating mast cell numbers and tryptase activity in human IPF [35, 36], and therapeutic targeting of CXCL12/CXCR4 signaling attenuated bleomycin induced lung fibrosis in mice [37, 38]. The gene discussed is CXCL12; the disease is idiopathic pulmonary fibrosis.